Market Overview

UPDATE: JP Morgan Downgrades Mead Johnson Nutrition to Neutral on Top-Line Concerns

Share:
Related MJN
Credit Suisse Reiterates Outperform, Raises Price Target On Mead Johnson Nutrition On Multiple Positive Factors
Earnings Scheduled For January 29, 2015
Mead Johnson CFO Leemputte stepping down (Seeking Alpha)

JP Morgan downgraded Mead Johnson Nutrition Company (NYSE: MJN) from Overweight to Neutral and lowered the price target from $71.00 to $68.00.

JP Morgan said, "With the stock trading at 20.5x NTM P/E and 13.2x EV/EBITDA, valuation metrics are near the high end of all consumer staples despite a great deal of uncertainty around near-term fundamentals. We are increasingly concerned about the top-line potential in 2013, and we think margins will get hit in 2H13 by higher dairy costs. We still consider MJN a fundamentally strong company but would look for a better entry point before buying the shares."

Mead Johnson Nutrition closed at $66.96 on Wednesday.

Latest Ratings for MJN

DateFirmActionFromTo
Jan 2015CitigroupMaintainsBuy
Jan 2015Morgan StanleyMaintainsEqual-weight
Jan 2015NomuraInitiates Coverage onBuy

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (MJN)

Around the Web, We're Loving...